BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 4 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $875,468 | -40.4% | 10,100 | -28.9% | 0.00% | -50.0% |
Q4 2022 | $1,469,558 | -3.7% | 14,200 | -21.1% | 0.00% | 0.0% |
Q3 2022 | $1,526,000 | -50.4% | 18,000 | -48.3% | 0.00% | -33.3% |
Q4 2021 | $3,075,000 | -25.1% | 34,800 | -29.3% | 0.00% | -40.0% |
Q2 2021 | $4,105,000 | -15.1% | 49,200 | -23.1% | 0.01% | -28.6% |
Q1 2021 | $4,833,000 | +45.8% | 64,000 | +69.3% | 0.01% | +75.0% |
Q4 2020 | $3,315,000 | +347.4% | 37,800 | +334.5% | 0.00% | +100.0% |
Q4 2018 | $741,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 35,000 | $3,403,400 | 0.01% |
SIMPLEX TRADING, LLC | 49,200 | $4,784 | 0.00% |
JANE STREET GROUP, LLC | 58,200 | $5,659,368 | 0.00% |
JPMORGAN CHASE & CO | 26,300 | $2,557,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |